Ernexa Therapeutics Inc.ERNANASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank22
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P22
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -9.97% |
| 2023 | -11.89% |
| 2022 | 12.44% |
| 2021 | 346.59% |
| 2020 | -74.93% |
| 2019 | -8.78% |
| 2018 | -6.69% |
| 2017 | -6.14% |
| 2016 | -8.87% |
| 2015 | 0.00% |